Effect of acetaminophen and nonsteroidal anti-inflammatory drugs on gene expression of mesenchymal stem cells

Tissue Engineering - Part A

Volumn 19, Issue 7-8, 2013, Pages 1039-1046

  Almaawi, Abdulaziz ^a   Wang, Hong Tian ^a   Ciobanu, Ovidiu ^a   Rowas, Sora A L ^a   Rampersad, Sonia ^a   Antoniou, John ^a   Mwale, Fackson ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; BIOMINERALIZATION; BODY FLUIDS; BONE; CARTILAGE; COLLAGEN; DRUG PRODUCTS; FLOWCHARTING; GENES; PHOSPHATASES; STEM CELLS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

ALKALINE PHOSPHATASE; BONE MARROW; BONE SIALOPROTEINS; CHONDROCYTES; CHONDROGENESIS; CHONDROGENIC MARKERS; DICLOFENAC; INTERVERTEBRAL DISCS; MARKER GENES; MESENCHYMAL STEM CELL; NAPROXENS; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; OSTEOCALCIN; OSTEOGENIC; REVERSE TRANSCRIPTION; STEM CELL DIFFERENTIATION; TYPE X COLLAGEN; UP-REGULATION;

CELL CULTURE;

AGGRECAN; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BONE SIALOPROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCALCIN; PARACETAMOL; RUNX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR RUNX2;

AGED; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; VERY ELDERLY;

ACETAMINOPHEN; AGED; AGED, 80 AND OVER; AGGRECANS; ALKALINE PHOSPHATASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE X; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOARTHRITIS; OSTEOCALCIN;

EID: 84874683655     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0129     Document Type: Article

References (46)

1. Hollander, A.P., Pidoux, I., Reiner, A., Rorabeck, C., Bourne, R., and Poole, A.R. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 96, 2859, 1995.
2. Aurich, M., Mwale, F., Reiner, A., Mollenhauer, J.A., Anders, J.O., Fuhrmann, R.A., Kuettner, K.E., Poole, A.R., and Cole, A.A. Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface. Arthritis Rheum 54, 244, 2006.
3. Roughley, P., Martens, D., Rantakokko, J., Alini, M., Mwale, F., and Antoniou, J. The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage. Eur Cell Mater 11, 1, discussion 7, 2006.
4. Felson, D.T., and Nevitt, M.C. The effects of estrogen on osteoarthritis. Curr Opin Rheumatol 10, 269, 1998.
5. von der Mark, K., Kirsch, T., Nerlich, A., Kuss, A., Weseloh, G., Gluckert, K., and Stoss, H. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 35, 806, 1992.
6. Tchetina, E., Mwale, F., and Poole, A.R. Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodeling, and cell differentiation. J Bone Miner Res 18, 844, 2003.
7. Hristova, G.I., Jarzem, P., Ouellet, J.A., Roughley, P.J., Epure, L.M., Antoniou, J., and Mwale, F. Calcification in human intervertebral disc degeneration and scoliosis. J Orthop Res 29, 1888, 2011.
8. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
9. Prockop, D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71, 1997.
10. Caplan, A.I., and Bruder, S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7, 259, 2001.
11. Barry, F., Boynton, R.E., Liu, B., and Murphy, J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268, 189, 2001
12. Jorgensen, C., Gordeladze, J., and Noel, D. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 15, 406, 2004.
13. Caplan, A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213, 341, 2007.
14. Nelea, V., Luo, L., Demers, C.N., Antoniou, J., Petit, A., Lerouge, S., Wertheimer, R.M., and Mwale, F. Selective inhibition of type X collagen expression in human mesenchymal stem cell differentiation on polymer substrates surface-modified by glow discharge plasma. J Biomed Mater Res A 75, 216, 2005.
15. Mwale, F., Girard-Lauriault, P.L., Wang, H.T., Lerouge, S., Antoniou, J., and Wertheimer, M.R. Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogenrich plasma polymer coatings. Tissue Eng 12, 2639, 2006.
16. Mwale, F., Wang, H.T., Nelea, V., Luo, L., Antoniou, J., and Wertheimer, M.R. The effect of glow discharge plasma surface modification of polymers on the osteogenic differentiation of committed human mesenchymal stem cells. Biomaterials 27, 2258, 2006.
17. Ishikawa, Y., Wu, L.N., Genge, B.R., Mwale, F., and Wuthier, R.E. Effects of calcitonin and parathyroid hormone on calcification of primary cultures of chicken growth plate chondrocytes. J Bone Miner Res 12, 356, 1997.
18. Wu, W., Mwale, F., Tchetina, E., Kojima, T., Yasuda, T., and Poole, A.R. Cartilage matrix resorption in skeletogenesis. Novartis Found Symp 232, 158, discussion 166, 2001.
19. Aubin, J.E. Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. J Cell Biochem 72, 396, 1999.
20. zur Nieden, N.I., Kempka, G., and Ahr, H.J. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71, 18, 2003.
21. Stein, G.S., Lian, J.B., van Wijnen, A.J., Stein, J.L., Montecino, M., Javed, A., Zaidi, S.K., Young, D.W., Choi, J.Y., and Pockwinse, S.M. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23, 4315, 2004.
22. Lian, J.B., and Stein, G.S. Runx2/Cbfa1: a multifunctional regulator of bone formation. Curr Pharm Des 9, 2677, 2003.
23. Nishioka, K., Dennis, J.E., Gao, J., Goldberg, V.M., and Caplan, A.I. Sustained Wnt protein expression in chondral constructs from mesenchymal stem cells. J Cell Physiol 203, 6, 2004.
24. Shen, M., Yoshida, E., Yan, W., Kawamoto, T., Suardita, K., Koyano, Y., Fujimoto, K., Noshiro, M., and Kato, Y. Basic helix-loophelix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J Biol Chem 277, 50112, 2002.
25. Mwale, F., Stachura, D., Roughley, P., and Antoniou, J. Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. J Orthop Res 24, 1791, 2006.
26. Richmond, J., Hunter, D., Irrgang, J., Jones, M.H., Levy, B., Marx, R., Snyder-Mackler, L., Watters, W.C., Haralson, R.H., Turkelson, C.M., Wies, J.L., Boyer, K.M., Anderson, S., St. Andre, J., Sluka, P., and McGowan, R. Treatment of osteoarthritis of the knee (nonarthroplasty). J Am Acad Orthop Surg 17, 591, 2009.
27. Berger, R.G. Nonsteroidal anti-inflammatory drugs: making the right choices. J Am Acad Orthop Surg 2, 255, 1994.
28. Colter, D.C., Class, R., DiGirolamo, C.M., and Prockop, D.J. Rapid expansion of recycling stem cells in cultures of plasticadherent cells from human bone marrow. Proc Natl Acad Sci U S A 97, 3213, 2000.
29. Sevelius, H., Runkel, R., Segre, E., and Bloomfield, S.S. Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. Br J Clin Pharmacol 10, 259, 1980.
30. Lefer, A.M., and Crossley, K. Mechanisms of the optimal protective effects of ibuprofen in acute myocardial ischemia. Adv Shock Res 3, 133, 1980.
31. Willis, J.V., Kendall, M.J., Flinn, R.M., Thornhill, D.P., and Welling, P.G. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol 16, 405, 1979.
32. Davies, N.M., McLachlan, A.J., Day, R.O., and Williams, K.M. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 38, 225, 2000.
33. Gelotte, C.K., Auiler, J.F., Lynch, J.M., Temple, A.R., and Slattery, J.T. Disposition of acetaminophenaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther 81, 840, 2007.
34. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162, 156, 1987.
35. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45, 2001.
36. Mwale, F., Billinghurst, C., Wu, W., Alini, M., Webber, C., Reiner, A., Ionescu, M., Poole, J., and Poole, A.R. Selective assembly and remodelling of collagens II and IX associated with expression of the chondrocyte hypertrophic phenotype. Dev Dyn 218, 648, 2000.
37. Kirsch, T., Ishikawa, Y., Mwale, F., and Wuthier, R.E. Roles of the nucleational core complex and collagens (types II and X) in calcification of growth plate cartilage matrix vesicles. J Biol Chem 269, 20103, 1994.
38. Christoffersen, J., and Landis, W.J. A contribution with review to the description of mineralization of bone and other calcified tissues in vivo. Anat Rec 230, 435, 1991.
39. Miller, G.J., and DeMarzo, A.M. Ultrastructural localization of matrix vesicles and alkaline phosphatase in the Swarm rat chondrosarcoma: their role in cartilage calcification. Bone 9, 235, 1988.
40. Miao, D., and Scutt, A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 50, 333, 2002.
41. Katzung, B.G. Basic & Clinical Pharmacology. New York: Lange Medical Books/McGraw Hill, 2004.
42. Vane, J.R., and Botting, R.M. Mechanism of action of antiinflammatory drugs. Scand J Rheumatol Suppl 102, 9, 1996.
43. Mycek, M.J., Harvey, R.A., and Champe, P.C. Pharmacology. Philadelphia: Lippincott-Raven, 1997.
44. Petit, A., Wang, H.T., Girard-Lauriault, P.L., Wertheimer, M.R., Antoniou, J., and Mwale, F. Novel insights into the mechanism of decreased expression of type X collagen in human mesenchymal stem cells from patients with osteoarthritis cultured on nitrogen-rich plasma polymers: implication of cyclooxygenase-1. J Biomed Mater Res A 94, 744, 2010.
45. Mwale, F., Rampersad, S., Richard, H., Guoying, Y., Al Rowas, S., Madiraju, P., Antoniou, J., and Laverty, S. The constitutive expression of type x collagen in mesenchymal stem cells from osteoarthritis patients is reproduced in a rabbit model of osteoarthritis. J Tissue Eng 2011, 587547, 2011.
46. Brandt, K.D., and Albrecht, M. Effect of naproxen sodium on the net synthesis of glycosaminoglycans and protein by normal canine articular cartilage in-vitro. J Pharm Pharmacol 42, 738, 1990.